These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 21339369
21. Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Petersson K, Stray-Pedersen B, Malm G, Forsgren M, Evengård B. Acta Obstet Gynecol Scand; 2000 Oct; 79(10):824-9. PubMed ID: 11304963 [Abstract] [Full Text] [Related]
22. Serosurveillance of varicella and hepatitis B infection after reported cases in medical students and the relationship between past varicella disease history and immunity status. Suwanpakdee D, Laohapand C, Moolasart V, Lomtong P, Krairojananan N, Srisawat P, Watanaveeradej V. J Med Assoc Thai; 2012 May; 95 Suppl 5():S80-5. PubMed ID: 22934450 [Abstract] [Full Text] [Related]
23. Fetal risk associated with rubella vaccination during pregnancy. Badilla X, Morice A, Avila-Aguero ML, Saenz E, Cerda I, Reef S, Castillo-Solórzano C. Pediatr Infect Dis J; 2007 Sep; 26(9):830-5. PubMed ID: 17721380 [Abstract] [Full Text] [Related]
24. Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight. Eskild A, Jenum PA, Bruu AL. Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1035-41. PubMed ID: 16232169 [Abstract] [Full Text] [Related]
25. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland. Morris A, Croxson M. N Z Med J; 2004 Feb 20; 117(1189):U770. PubMed ID: 15014559 [Abstract] [Full Text] [Related]
26. Performance of US hospitals on recommended screening and immunization practices for pregnant and postpartum women. Bath SK, Singleton JA, Strikas RA, Stevenson JM, McDonald LL, Williams WW. Am J Infect Control; 2000 Oct 20; 28(5):327-32. PubMed ID: 11029130 [Abstract] [Full Text] [Related]
27. Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002. da Silva e Sá GR, Camacho LA, Stavola MS, Lemos XR, Basílio de Oliveira CA, Siqueira MM. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S722-8. PubMed ID: 21954273 [Abstract] [Full Text] [Related]
31. TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections. Stegmann BJ, Carey JC. Curr Womens Health Rep; 2002 Aug 01; 2(4):253-8. PubMed ID: 12150751 [Abstract] [Full Text] [Related]
32. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Tamer GS, Dundar D, Caliskan E. Clin Invest Med; 2009 Feb 01; 32(1):E43-7. PubMed ID: 19178878 [Abstract] [Full Text] [Related]
40. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B. Am J Infect Control; 2006 Nov 01; 34(9):583-7. PubMed ID: 17097453 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]